Bioptik Technology Incorporation
Research Bioptik Technology Incorporation (4161.TWO) on Bullrun: market cap TWD 1.28B, P/E 11.6, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4161.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 1.28B
- P/E11.6
- Dividend yield3.3%
- Financial periodQ2 2026
- RevenueTWD 237.60M
- Net incomeTWD 38.57M
- Free cash flowTWD 94.95M
- Gross margin26.8%
Valuation Snapshot
latest market cap is TWD 1.28B; P/E is 11.6; dividend yield is 3.3%.
Peer valuation comparison
Latest P/E is 11.57x versus a Healthcare sector median of 21.8x (46.9% below).
Latest dividend yield is 3.32% versus a Healthcare sector median of 2.4% (38.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.28B | 11.6 | 3.3% | 0.7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.7 TWD, yield 3.3%.
About Bioptik Technology Incorporation
Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bioptik Technology Incorporation's market cap?
Bioptik Technology Incorporation's market capitalization is TWD 1.28B.
What is Bioptik Technology Incorporation's P/E ratio?
Bioptik Technology Incorporation's price-to-earnings (P/E) ratio is 11.6.
Does Bioptik Technology Incorporation pay a dividend?
Bioptik Technology Incorporation has a dividend yield of 3.3%.
What does Bioptik Technology Incorporation do?
Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats.